DR. GARY ZAMMIT TO PRESENT AT CIT HEALTHCARE CONFERENCE
– Dr. Gary Zammit, President & CEO of Clinilabs, is scheduled to present at the Third Annual CIT Healthcare Conference. This event will take place at the Waldorf Astoria Hotel in New York City on Tuesday, April 29, bringing together healthcare companies with potential sources of capital and strategic partners.
CIT Healthcare is a corporate and investment banking firm that offers a full spectrum of financing solutions and related advisory services to companies across the healthcare industry. The objective of the conference is to provide companies with an opportunity to develop relationships, identify new sources of capital, and learn more about the various segments within the healthcare industry.
This year’s conference will include presentations from over thirty-five companies in various sectors of healthcare. In addition, former U.S. Senate Majority Leader, Bill Frist, MD, will be the keynote speaker. Dr. Frist is recognized among the most influential leaders in American healthcare.
The CIT Healthcare Conference provides an opportunity for presenters and potential investors to be able to meet one-on-one, where they can speak in depth about future opportunities of working together. “It is a privilege to be among the presenters at the conference,” stated Dr. Zammit. “It offers a very good opportunity to interact with potential investors and develop relationships with future strategic partners,” he added.
Dr. Zammit received his PhD degree in clinical psychology from the University of Toledo and completed his clinical internship and fellowship at the New York Hospital – Cornell University Medical College. He has served on the Scientific Advisory Boards for seven of the top 20 pharma companies, as well as multiple biotechnology companies. He is also a Clinical Associate Professor at the Columbia University College of Physicians and Surgeons. Dr. Zammit founded Clinilabs in 2001.
Clinilabs is a specialty contract research organization (CRO) that provides a full portfolio of services to pharmaceutical, biotechnology, and medical device companies involved in the development of central nervous system (CNS) and cardiovascular (CV) therapeutics. The Company also provides early phase services in a wider range of therapeutic areas at its Phase I facility. Established in 2001, Clinilabs has provided services to more than one third of the world’s top 20 pharmaceutical companies, and has been involved in more than 10 successful New Drug Applications (NDAs) in central nervous system (CNS) and cardiovascular (CV) indications.
CIT Healthcare is part of CIT (NYSE: CIT), a global commercial finance company that provides financial products and advisory services to more than one million customers in over 50 countries across 30 industries. CIT Healthcare offers a full suite of corporate finance products and strategic advisory services, designed to meet the diverse commercial financing needs of healthcare providers.
For more information on the CIT Healthcare Conference or to request a registration form, please visit http://healthcareconference.cit.com or e-mail healthcare@cit.com.
Contact:
Jeanine M. Estrada
212-981-2716
jestrada@clinilabs.com |
